Luigi Bolondi

40.8k citations
278 papers · 18.4k indexed · 10 hit papers · h-index 66
Topics
Hepatocellular Carcinoma Treatment and Prognosis (133 papers)Liver Disease Diagnosis and Treatment (111 papers)Liver Disease and Transplantation (102 papers)
Partner nations
ItalyUnited StatesFrance

In The Last Decade

Luigi Bolondi

271 papers receiving 18.0k citations

Hit Papers

Adjuvant sorafenib for hepato...199520262005201520151995200720122016250500750

Peers

Luigi Bolondi
Comparison fields: 5 of 148
  • Hepatology 12.4k
  • Epidemiology 8.4k
  • Surgery 4.1k
  • Cancer Research 3.0k
  • Molecular Biology 3.0k
Replace Philip J. Johnson with:
Philip J. Johnson United Kingdom
Kwang‐Hyub Han South Korea
Fabio Piscaglia Italy
Tadatoshi Takayama Japan
Markus Peck‐Radosavljevic Austria
Wan Yee Lau China
Yasuni Nakanuma Japan
Masamichi Kojiro Japan
Myron Schwartz United States
Osamu Yokosuka Japan
Luigi Bolondi relative to Philip J. Johnson United Kingdom Philip J. Johnson's profile →
Citations per field
00.5×1.5×
Philip J. Johnson · 1×
Citations per year

Countries citing papers authored by Luigi Bolondi

Since Specialization
Citations

This map shows the geographic impact of Luigi Bolondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Bolondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Bolondi more than expected).

Fields of papers citing papers by Luigi Bolondi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Bolondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Bolondi. The network helps show where Luigi Bolondi may publish in the future.

Co-authorship network of co-authors of Luigi Bolondi

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Bolondi. A scholar is included among the top collaborators of Luigi Bolondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Bolondi. Luigi Bolondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 118
2
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidencebreakdown →
429
3 137
4 12
5 343
6 343
7 20
8
Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinomabreakdown →
670
9 35
10 333
11 81
12 37
13
Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
18
14 4
15 211
16 35
17 327
18 39
19 12
20 9

About Luigi Bolondi

Luigi Bolondi is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 278 papers that have together received 18.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (133 papers), Liver Disease Diagnosis and Treatment (111 papers) and Liver Disease and Transplantation (102 papers). The work is most often cited by research in Hepatology (12.4k citations), Epidemiology (8.4k citations) and Cancer Research (3.0k citations). Luigi Bolondi has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Fabio Piscaglia, Laura Gramantieri, Stefano Gaiani, Rita Golfieri, Jean‐Luc Raoul, Vincenzo Mazzaferro, Alessandro Cucchetti, Gian Luca Grazi, Tito Livraghi and Gianni Zironi. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026